QVT Financial LP, Director, 10% Owner at Roivant Sciences Ltd. (ROIV), sold 12,508,362 shares at $4.75 ($53.7M) on 2022-11-10, disclosed to the SEC on 2022-11-14.
Open-market sale of $53.7M ROIV by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,196,200 | $0 | 0.0% |
| 2 | $4.75 | 146,079 | $694K | 1.3% |
| 3 | $4.75 | 146,079 | $694K | 1.3% |
| 4 | $4.75 | 372,427 | $1.8M | 3.3% |
| 5 | $4.75 | 372,427 | $1.8M | 3.3% |
| 6 | $4.75 | 1,092,355 |
| $5.2M |
| 9.7% |
| 7 | $4.75 | 1,092,355 | $5.2M | 9.7% |
| 8 | $4.75 | 1,733,577 | $8.2M | 15.3% |
| 9 | $4.75 | 1,733,577 | $8.2M | 15.3% |
| 10 | $4.75 | 2,311,643 | $11.0M | 20.4% |
| 11 | $4.75 | 2,311,643 | $11.0M | 20.4% |
| Total | $4.30 avg | 12,508,362 | $53.7M | 100% |
| Filing → |
| ROIV | SELL | 2026-02-13 | $32.7M | — | Filing → |
| ROIV | SELL | 2025-12-18 | $71.8M | — | Filing → |
| ROIV | SELL | 2025-11-21 | $29.8M | — | Filing → |